2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$139.64+$0.11 (+0.08%)
Price as of Oct 22, 2026 7:30 PM EDT- $8.9BMarket Cap
- 87.86%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$139.64+$0.11 (+0.08%)
Earnings Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 4.89% | ||
12-Month Momentum | 93.43% | ||
3-Month Risk Adjusted Momentum | 35.26% | ||
12-Month Risk Adjusted Momentum | 243.67% |
True Yield
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.53% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 12 |